News
Seqirus Announces U.S. $140 Million Manufacturing Expansion to Meet Growing Demand for Innovative Cell-Based Influenza Vaccines
16-Nov-2018Seqirus Announces U.S. $140 Million ...
Seqirus Cell-based Influenza Vaccine Nears European Approval
10-Oct-2018Seqirus, a global leader in influenza prevention ...
Human Vaccines Project and Seqirus Partner To Advance Universal Flu Vaccine Research
26-Jun-2018Seqirus is joining the Universal
Influenza ...
New PNG Snakebite Project to Improve Access to Antivenoms
17-Apr-2018A new partnership to help save the lives of ...
Be FLUent Partnership Shines Spotlight on Importance of Flu Prevention in Seniors
04-Dec-2017Seqirus partners with American Nurse ...